Kestra Medical Technologies (KMTS) Common Equity (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Common Equity of $259.7 million for Q2 2026, up 26.41% year-over-year from $205.4 million in Q2 2025, and down 9.84% quarter-over-quarter from $288.0 million in Q1 2026.
Kestra Medical Technologies (KMTS) Common Equity (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Common Equity for 3 consecutive years, with $259.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 26.41% year-over-year to $259.7 million; the TTM figure through Apr 2026 stood at $259.7 million (up 26.41% YoY), while the FY2026 annual figure was $259.7 million, up 26.41% from the prior year.
- Common Equity eased to $259.7 million in Q2 2026 per KMTS's latest filing, from $288.0 million in the prior quarter.
- Across five years, Common Equity topped out at $288.0 million in Q1 2026 and bottomed at -$384.2 million in Q1 2024.
- Historically, Common Equity has averaged -$20.3 million across 3 years, with a median of -$22.6 million in 2024.
- On a YoY basis, Common Equity climbed as much as 211.67% in 2026 and fell as far as 26.41% in 2026.
- Kestra Medical Technologies' Common Equity stood at -$236.5 million in 2024, then surged by 169.37% to $164.1 million in 2025, then surged by 58.25% to $259.7 million in 2026.
- Business Quant data shows KMTS's Common Equity at $259.7 million in Q2 2026, $288.0 million in Q1 2026, and $164.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | 259.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 259.66 Mn |
| Jan 31, 2026 | 287.99 Mn |
| Oct 31, 2025 | 164.08 Mn |
| Jul 31, 2025 | 184.16 Mn |
| Apr 30, 2025 | 205.41 Mn |
| Jan 31, 2025 | -257.90 Mn |
| Oct 31, 2024 | -236.55 Mn |
| Jul 31, 2024 | -216.47 Mn |
| Apr 30, 2024 | -209.38 Mn |
| Jan 31, 2024 | -384.15 Mn |